Last 7 days
-4.8%
Last 30 days
-4.6%
Last 90 days
1.7%
Trailing 12 Months
47.7%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-30 | Favorite Annette F | acquired | 166,940 | 83.47 | 2,000 | sr. vp & chief hr officer |
2023-08-30 | Favorite Annette F | sold | -829,277 | 414 | -2,000 | sr. vp & chief hr officer |
2023-08-22 | Reiss-Clark Cindy | acquired | 915,007 | 263 | 3,477 | chief commercial officer |
2023-08-22 | Reiss-Clark Cindy | sold | -1,367,640 | 393 | -3,477 | chief commercial officer |
2023-08-11 | Lai Quintin J | sold | -8,337,490 | 395 | -21,101 | vp strat & investor relations |
2023-08-11 | Lai Quintin J | acquired | 2,646,110 | 125 | 21,101 | vp strat & investor relations |
2023-08-09 | Witherspoon Charles | acquired | 231,613 | 137 | 1,680 | vp & treasurer |
2023-08-09 | Witherspoon Charles | sold | -666,187 | 396 | -1,680 | vp & treasurer |
2023-08-08 | Green Eric Mark | sold | -17,369,800 | 394 | -44,000 | president & ceo |
2023-08-08 | Abraham Silji | acquired | 836,482 | 102 | 8,160 | svp, chief technology officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Jefferies Group LLC | new | - | 2,429,790 | 2,429,790 | 0.02% |
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | 217 | 2,301 | -% |
2023-09-20 | BARCLAYS PLC | added | 84.93 | 25,507,000 | 50,000,000 | 0.03% |
2023-09-12 | Farther Finance Advisors, LLC | added | 28.25 | 25,501 | 86,829 | 0.02% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | 756 | 8,032 | -% |
2023-09-05 | Covenant Partners, LLC | unchanged | - | 31,788 | 337,721 | 0.12% |
2023-09-01 | Portside Wealth Group, LLC | new | - | 1,031,520 | 1,031,520 | 0.19% |
2023-08-30 | Western Wealth Management, LLC | unchanged | - | 49,972 | 530,883 | 0.04% |
2023-08-28 | DT Investment Partners, LLC | unchanged | - | 227 | 15,239 | -% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | 671,688 | 7,136,120 | 0.07% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 3.1% | 2,301,161 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 12.14% | 8,988,409 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 11.0% | 8,148,624 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 8.4% | 6,241,901 | SC 13G/A | |
Feb 04, 2022 | franklin resources inc | 3.8% | 2,848,869 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 10.9% | 8,094,288 | SC 13G/A | |
Jan 25, 2022 | blackrock inc. | 10.9% | 8,094,288 | SC 13G/A | |
Apr 12, 2021 | blackrock inc. | 10.1% | 7,467,809 | SC 13G/A | |
Feb 16, 2021 | price t rowe associates inc /md/ | 6.2% | 4,624,247 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 11.21% | 8,289,370 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 21, 2023 | 8-K/A | Current Report | |
Sep 01, 2023 | 4 | Insider Trading | |
Aug 24, 2023 | 4 | Insider Trading | |
Aug 15, 2023 | 4 | Insider Trading | |
Aug 11, 2023 | 4 | Insider Trading | |
Aug 10, 2023 | 4 | Insider Trading | |
Aug 10, 2023 | 4 | Insider Trading | |
Aug 08, 2023 | 4 | Insider Trading | |
Aug 08, 2023 | 144 | Notice of Insider Sale Intent | |
Jul 27, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 182.5B | 30.4B | -1.37% | -4.99% | 28.7 | 6.01 | -1.49% | 0.14% |
ABT | 167.5B | 40.2B | -6.47% | -2.73% | 32.45 | 4.16 | -11.68% | -39.67% |
MDT | 105.0B | 31.6B | -2.70% | -3.25% | 28.96 | 3.33 | 1.57% | -30.40% |
IDXX | 35.9B | 3.5B | -11.25% | 30.83% | 45.38 | 10.22 | 6.21% | 19.20% |
WST | 27.7B | 2.9B | -4.60% | 47.73% | 53.48 | 9.68 | -2.14% | -24.34% |
MID-CAP | ||||||||
PEN | 9.5B | 937.8M | -1.70% | 33.64% | 325.17 | 10.1 | 16.30% | 250.21% |
LNTH | 4.5B | 1.1B | -2.64% | -5.47% | 135.07 | 4.01 | 69.36% | 3.03% |
NEOG | 4.2B | 822.4M | -14.46% | 31.58% | -184 | 5.12 | 56.01% | -147.34% |
QDEL | - | - | -7.20% | -1.41% | - | - | - | - |
SMALL-CAP | ||||||||
VIVO | 1.5B | 301.6M | 2.29% | 56.91% | -550.1 | 4.93 | -3.75% | -104.51% |
HSKA | 1.2B | 254.9M | 2.45% | 31.18% | -62.25 | 4.89 | -1.22% | 15.74% |
CYRX | 653.5M | 240.7M | -3.82% | -45.97% | -15.31 | 2.72 | 4.82% | 85.44% |
AWH | 45.4M | 9.0M | 48.55% | -15.88% | -2.52 | 5.03 | 20.81% | 50.13% |
QTNT | 766.7K | 37.4M | -50.00% | -99.61% | -0.01 | 0.02 | -2.49% | 10.49% |
25.4%
27.1%
25.5%
11.8%
66.9%
27.3%
11.5%
Y-axis is the maximum loss one would have experienced if West Pharmaceutical Services was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -0.6% | 2,866 | 2,884 | 2,887 | 2,909 | 2,929 | 2,881 | 2,832 | 2,681 | 2,523 | 2,326 | 2,147 | 2,037 | 1,945 | 1,888 | 1,840 | 1,792 | 1,767 | 1,745 | 1,717 | 1,711 | 1,677 |
Gross Profit | -2.7% | 1,093 | 1,123 | 1,136 | 1,175 | 1,195 | 1,189 | 1,176 | 1,086 | 993 | 873 | 768 | 710 | 663 | 626 | 606 | 586 | 574 | 558 | 545 | 541 | 530 |
S&GA Expenses | 2.2% | 326 | 320 | 317 | 329 | 355 | 366 | 363 | 341 | 325 | 310 | 302 | 295 | 283 | 276 | 273 | 263 | 264 | 263 | 263 | 263 | 261 |
R&D Expenses | 3.4% | 63.00 | 61.00 | 59.00 | 56.00 | 56.00 | 55.00 | 53.00 | 52.00 | 51.00 | 48.00 | 47.00 | 44.00 | 41.00 | 40.00 | 39.00 | 39.00 | 39.00 | 41.00 | 40.00 | 40.00 | 39.00 |
EBITDA | -100.0% | - | 777 | 805 | 861 | 906 | 893 | 879 | 806 | 721 | 607 | 519 | 475 | 442 | 420 | 404 | 393 | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.27* | 0.28* | 0.30* | 0.31* | 0.31* | 0.31* | 0.30* | 0.29* | 0.26* | 0.24* | 0.23* | 0.23* | 0.22* | 0.22* | 0.22* | - | - | - | - | - |
Interest Expenses | 11.4% | 9.00 | 8.00 | 8.00 | 9.00 | 8.00 | 9.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 9.00 | 9.00 | 9.00 | 9.00 | 8.00 | 8.00 | 8.00 |
Earnings Before Taxes | -6.5% | 608 | 650 | 680 | 733 | 778 | 762 | 749 | 682 | 599 | 490 | 401 | 364 | 331 | 308 | 292 | 280 | 276 | 257 | 241 | 234 | 236 |
EBT Margin | -100.0% | - | 0.23* | 0.24* | 0.25* | 0.27* | 0.26* | 0.26* | 0.25* | 0.24* | 0.21* | 0.19* | 0.18* | 0.17* | 0.16* | 0.16* | 0.16* | - | - | - | - | - |
Net Income | -6.0% | 519 | 552 | 586 | 631 | 686 | 684 | 662 | 613 | 519 | 423 | 346 | 312 | 286 | 261 | 242 | 230 | 229 | 219 | 207 | 155 | 151 |
Net Income Margin | -100.0% | - | 0.19* | 0.20* | 0.22* | 0.23* | 0.24* | 0.23* | 0.23* | 0.21* | 0.18* | 0.16* | 0.15* | 0.15* | 0.14* | 0.13* | 0.13* | - | - | - | - | - |
Free Cashflow | -100.0% | - | 410 | 439 | 388 | 402 | 382 | 331 | 337 | 284 | 307 | 298 | 276 | 281 | 247 | 241 | 215 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -1.5% | 3,670 | 3,724 | 3,617 | 3,317 | 3,362 | 3,295 | 3,314 | 3,143 | 2,934 | 2,740 | 2,794 | 2,583 | 2,392 | 2,247 | 2,341 | 2,174 | 2,123 | 2,036 | 1,979 | 1,946 | 1,874 |
Current Assets | -3.3% | 1,874 | 1,937 | 1,920 | 1,734 | 1,771 | 1,691 | 1,742 | 1,598 | 1,477 | 1,327 | 1,374 | 1,238 | 1,111 | 978 | 1,059 | 1,004 | 944 | 868 | 894 | 850 | 767 |
Cash Equivalents | -10.2% | 796 | 886 | 894 | 729 | 719 | 668 | 763 | 688 | 576 | 484 | 616 | 519 | 446 | 335 | 439 | 396 | 327 | 266 | 337 | 297 | 226 |
Inventory | 0.5% | 449 | 447 | 415 | 413 | 412 | 417 | 378 | 354 | 345 | 310 | 321 | 295 | 275 | 251 | 236 | 230 | 232 | 226 | 215 | 207 | 208 |
Net PPE | 3.8% | 1,261 | 1,215 | 1,158 | 1,069 | 1,077 | 1,066 | 1,058 | 1,007 | 973 | 931 | 943 | 883 | 840 | 828 | 839 | 812 | 823 | 815 | 822 | 822 | 827 |
Goodwill | 0.2% | 108 | 108 | 107 | 104 | 107 | 109 | 110 | 109 | 110 | 110 | 111 | 109 | 108 | 107 | 108 | 107 | 108 | 105 | 106 | 106 | 107 |
Liabilities | -2.6% | 923 | 947 | 932 | 846 | 937 | 969 | 978 | 940 | 901 | 911 | 939 | 864 | 786 | 756 | 768 | 686 | 678 | 667 | 583 | 594 | 592 |
Current Liabilities | -4.4% | 512 | 535 | 519 | 457 | 565 | 585 | 594 | 559 | 473 | 483 | 503 | 448 | 375 | 344 | 342 | 335 | 313 | 301 | 284 | 289 | 288 |
LT Debt, Non Current | -0.2% | 206 | 206 | 207 | 207 | 208 | 208 | 209 | 210 | 252 | 252 | 253 | 253 | 254 | 254 | 255 | 195 | 196 | 196 | 196 | 196 | 196 |
Shareholder's Equity | -1.1% | 2,747 | 2,776 | 2,685 | 2,471 | 2,424 | 2,326 | 2,335 | 2,202 | 2,033 | 1,829 | 1,855 | 1,719 | 1,606 | 1,490 | 1,573 | 1,488 | 1,445 | 1,370 | 1,396 | 1,352 | 1,282 |
Retained Earnings | 4.5% | 3,255 | 3,114 | 2,988 | 2,913 | 2,793 | 2,617 | 2,457 | 2,336 | 2,160 | 1,985 | 1,847 | 1,773 | 1,703 | 1,612 | 1,549 | 1,497 | 1,453 | 1,398 | 1,353 | 1,313 | 1,258 |
Additional Paid-In Capital | -12.8% | 158 | 181 | 232 | 231 | 225 | 220 | 249 | 251 | 248 | 247 | 267 | 268 | 263 | 268 | 273 | 269 | 273 | 279 | 282 | 283 | 305 |
Accumulated Depreciation | 1.4% | 1,282 | 1,264 | 1,228 | 1,164 | 1,169 | 1,171 | 1,158 | 1,140 | 1,125 | 1,098 | 1,092 | 1,056 | 1,018 | 989 | 981 | 968 | 964 | 945 | 931 | 924 | 910 |
Shares Outstanding | -0.4% | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -0.5% | 707 | 711 | 724 | 654 | 675 | 647 | 584 | 572 | 500 | 504 | 473 | 430 | 420 | 377 | 367 | 334 | 314 | 291 | 289 | 297 | 284 |
Share Based Compensation | 7.5% | 29.00 | 27.00 | 24.00 | 27.00 | 32.00 | 37.00 | 38.00 | 34.00 | 33.00 | 35.00 | 34.00 | 33.00 | 29.00 | 24.00 | 24.00 | 19.00 | 19.00 | 18.00 | 15.00 | 17.00 | 17.00 |
Cashflow From Investing | -5.3% | -318 | -302 | -288 | -270 | -277 | -266 | -253 | -233 | -217 | -202 | -179 | -242 | -225 | -231 | -228 | -136 | -130 | -100 | -100 | -101 | -109 |
Cashflow From Financing | -73.3% | -332 | -191 | -293 | -290 | -220 | -184 | -168 | -170 | -172 | -173 | -137 | -77.40 | -70.60 | -66.60 | -36.80 | -96.00 | -85.50 | -114 | -80.70 | -159 | -172 |
Dividend Payments | 1.8% | 56.00 | 55.00 | 54.00 | 53.00 | 52.00 | 52.00 | 51.00 | 50.00 | 50.00 | 49.00 | 48.00 | 47.00 | 47.00 | 46.00 | 45.00 | 44.00 | 44.00 | 43.00 | 42.00 | 41.00 | 41.00 |
Buy Backs | 125.0% | 261 | 116 | 203 | 203 | 176 | 147 | 137 | 137 | 137 | 137 | 116 | 116 | 116 | 116 | 83.00 | 83.00 | 83.00 | 106 | 71.00 | 118 | 118 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Net sales | $ 753.8 | $ 771.3 | $ 1,470.4 | $ 1,491.3 |
Cost of goods and services sold | 462.4 | 449.8 | 907.7 | 885.2 |
Gross profit | 291.4 | 321.5 | 562.7 | 606.1 |
Research and development | 16.5 | 14.4 | 33.6 | 29.0 |
Selling, general and administrative expenses | 88.4 | 81.5 | 174.4 | 164.9 |
Other expense (income) (Note 15) | 4.0 | (2.8) | 16.9 | (5.9) |
Operating profit | 182.5 | 228.4 | 337.8 | 418.1 |
Interest expense, net | 2.7 | 1.8 | 4.9 | 4.0 |
Interest income | (5.0) | (0.4) | (9.8) | (0.7) |
Other nonoperating (income) expense | (0.1) | (0.2) | (0.1) | (0.2) |
Income before income taxes and equity in net income of affiliated companies | 184.9 | 227.2 | 342.8 | 415.0 |
Income tax expense | 34.8 | 44.2 | 58.4 | 65.4 |
Equity in net income of affiliated companies | (5.0) | (5.5) | (10.7) | (12.7) |
Net income | $ 155.1 | $ 188.5 | $ 295.1 | $ 362.3 |
Net income per share: | ||||
Basic (in dollars per share) | $ 2.08 | $ 2.53 | $ 3.96 | $ 4.87 |
Diluted (in dollars per share) | $ 2.06 | $ 2.48 | $ 3.91 | $ 4.77 |
Weighted average shares outstanding: | ||||
Basic (in shares) | 74.3 | 74.4 | 74.4 | 74.4 |
Diluted (in shares) | 75.4 | 75.8 | 75.5 | 75.9 |
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 796.3 | $ 894.3 |
Accounts receivable, net | 534.4 | 507.4 |
Inventories | 449.4 | 414.8 |
Other current assets | 94.1 | 103.0 |
Total current assets | 1,874.2 | 1,919.5 |
Property, plant and equipment | 2,543.3 | 2,386.6 |
Less: accumulated depreciation and amortization | 1,282.0 | 1,228.3 |
Property, plant and equipment, net | 1,261.3 | 1,158.3 |
Operating lease right-of-use assets | 99.2 | 104.4 |
Investments in affiliated companies | 202.8 | 204.9 |
Goodwill | 108.0 | 107.3 |
Intangible assets, net | 16.8 | 18.4 |
Deferred income taxes | 67.0 | 65.6 |
Other noncurrent assets | 40.3 | 38.4 |
Total Assets | 3,669.6 | 3,616.8 |
Current liabilities: | ||
Notes payable and other current debt | 2.2 | 2.2 |
Accounts payable | 218.0 | 215.4 |
Accrued salaries, wages and benefits | 85.4 | 76.8 |
Income taxes payable | 26.7 | 24.8 |
Operating lease liabilities | 16.2 | 16.0 |
Other current liabilities | 163.1 | 183.8 |
Total current liabilities | 511.6 | 519.0 |
Long-term debt | 205.6 | 206.7 |
Deferred income taxes | 15.4 | 14.3 |
Pension and other postretirement benefits | 27.3 | 28.2 |
Operating lease liabilities | 87.3 | 93.0 |
Deferred compensation benefits | 20.6 | 19.1 |
Other long-term liabilities | 55.1 | 51.6 |
Total Liabilities | 922.9 | 931.9 |
Commitments and contingencies | ||
Equity: | ||
Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding | 0.0 | 0.0 |
Common stock, par value $0.25 per share; 200.0 million shares authorized; shares issued: 75.3 million and 75.3 million; shares outstanding: 73.9 million and 74.1 million | 18.8 | 18.8 |
Capital in excess of par value | 158.2 | 232.2 |
Retained earnings | 3,254.6 | 2,987.8 |
Accumulated other comprehensive loss | (183.5) | (183.0) |
Treasury stock, at cost (1.4 million and 1.2 million shares) | (501.4) | (370.9) |
Total Equity | 2,746.7 | 2,684.9 |
Total Liabilities and Equity | $ 3,669.6 | $ 3,616.8 |